RyanCRamaekersMD

PubMed

• 6 citations
  A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
  Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, Shuli Li, Ilana F Gareen, Keith T Flaherty, Benjamin A Herman, Susan M Domchek, Angela M DeMichele, Kara N Maxwel...> ;Cancer. 2022 Apr 1
• ASCO's Selection of Oncologist Workforce Data Source.
  M. Kelsey Kirkwood, Suanna S. Bruinooge, Laura A. Levit, Caroline Schenkel, Michael P. Kosty, Todd A. Pickard, Ryan C Ramaekers, Stephanie F. Williams> ;JCO Oncology Practice. 2021 May 11
• 9 citations
  Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy
  David Crockett, Dron Gauchan, Ryan Ramaekers, Kris Mleczko> ;Journal of Clinical Oncology. 2018 May 15
• 8 citations
  Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
  Curtis Gnewuch, Megan Schriner, Mark Tharnish, Mithat Gonen, Monica McDonald, Jami Kezeor, Ryan Ramaekers, Dron Gauchan, Douglas Clark, Lois Greenwalt, M. Mickey, Max ...> ;Journal of Oncology Pharmacy Practice. 2018 Mar 1
• 4 citations
  Neoadjuvant Chemotherapy or Primary Debulking Surgery for Stage IIIC Ovarian Cancer
  Dron Gauchan, Ryan Ramaekers, David Crockett, Douglas Clark> ;Journal of Clinical Oncology. 2017 Mar 1
• 2 citations
  Normalization of Elevated Tumor Marker CA27-29 After Bilateral Lung Transplantation in a Patient With Breast Cancer and Idiopathic Pulmonary Fibrosis.
  Julie Marie Wurdeman, Debra Nelson, Ryan Ramaekers, Dron Gauchan, David Crockett> ;Oncology Research. 2017 Dec 11
• 3 citations
  Is It Time to Reconsider Prophylactic Cranial Radiation in Non–Small-Cell Lung Cancer?
  Ryan C. Ramaekers, Douglas Clark, Max Norvell, Dron Gauchan> ;Journal of Clinical Oncology. 2016 Sep 27
• 1 citations
  Recent ASCO Guideline on the Use of Biomarkers for Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer
  Ryan C. Ramaekers, Dron Gauchan, Max Norvell, Douglas Clark> ;Journal of Clinical Oncology. 2016 Aug 22
• What Is the Optimal Dose and Schedule for Dasatinib in Chronic Myeloid Leukemia: Two Case Reports and Review of the Literature.
  Jamison C, Nelson D, Eren M, Gauchan D, Ramaekers R, Norvell M, Copur MS> ;Oncol. Res.. 2016-01-01
• 22 citations
  ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska
  Ryan Ramaekers, Mithat Gonen, Mary Gulzow, Rebecca Hadenfeldt, Courtney Fuller, Jenifer Scott, Sarah Einspahr, Heather Benzel, Mary Mickey, Max Norvell, Douglas Clark,...> ;Journal of Oncology Practice. 2016 Jan 1
• 5 citations
  Radiation Recall Pneumonitis During Systemic Treatment With Everolimus.
  Douglas Clark, Dron Gauchan, Ryan Ramaekers, Max Norvell> ;Oncology Research. 2015 Nov 25
• 1 citations
  Germline BRCA1/2 Mutations: Are They Good Enough to Determine Who Will Respond to Poly(ADP-Ribose) Polymerase Inhibitor Therapy in Advanced Cancer?
  Dron Gauchan, Kimberly Brussow, Douglas Clark, Ryan C. Ramaekers> ;Journal of Clinical Oncology. 2015 Jun 29
• 2 citations
  Cost-Effectiveness of Molecular Profiling for Early Breast Cancer
  Dron Gauchan, Ryan C. Ramaekers, Sitki M. Copur> ;Journal of Clinical Oncology. 2015 Apr 6
• Pazopanib versus sunitinib in renal cancer.
  Ramaekers R Tharnish M Copur MS> ;N Engl J Med. 2013 Nov 14
• 1 citations
  Anastrozole and fulvestrant in metastatic breast cancer.
  Ramaekers R, Jabbour M, Mehmet Sitki Copur> ;The New England Journal of Medicine. 2012 Oct 25
• 3 citations
  Bevacizumab in ovarian cancer.
  Mehmet Sitki Copur, Angela Mae Obermiller, Ryan C. Ramaekers> ;The New England Journal of Medicine. 2012 Mar 29
• Fulvestrant (F) and letrozole (L) combination in second-line or more for estrogen receptor (ER)-positive (+) metastatic breast cancer (MBC): Efficacy and predictive fa...
  Obermiller AM, Copur MS, Bolton M, Ramaekers RC, Hays R, Nelson D, Benzel H, Mickey M, Norvell M, Olsen J, Tharnish M, Luebbe B, Schneider S, Woodward S, Keenportz B, ...> ;J. Clin. Oncol.. 2011-05-20
• Clinical trial enrollment (CTE) and related activities in a community-based cancer center (CBCC) in rural Nebraska before and after National Community Cancer Centers P...
  Ramaekers RC, Benzel H, Loberiza FR, Obermiller AM, Fuller C, Gulzow M, Hadenfeldt R, Nielsen N, Norvell M, Mickey M, Goering J, Copur MS> ;J. Clin. Oncol.. 2011-05-20
• Cancer genetic counseling services (GCS) in a community-based cancer center (CBCC) in rural Nebraska: Effect of National Community Cancer Centers Program (NCCCP).
  Copur MS, Percich S, Jordan A, Obermiller AM, Loberiza FR, Benzel H, Langford-Karre J, Mickey M, Norvell M, Friesen L, Bolton M, Mleczko K, Ramaekers RC> ;J. Clin. Oncol.. 2011-05-20
• Phase I study of imatinib in combination with gemcitabine and capecitabine.
  Ramaekers RC, Elkahwaji J, Reed E, Ganti A, Wang J, Grem J, Baranowska-Kortylewicz J, Hauke R> ;J. Clin. Oncol.. 2009-05-20
• 24 citations
  The Characteristics of Successful Family Physicians in Rural Nebraska: A Qualitative Study of Physician Interviews.
  Elisabeth L. Backer, Helen E. McIlvain, Paul Mark Paulman, Ryan C. Ramaekers> ;The Journal of Rural Health. 2006 Apr 1
• Join now to see all